avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tcf3
|
ENSMUSG00000020167.8 | transcription factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tcf3 | mm10_v2_chr10_-_80433615_80433655 | 0.85 | 3.4e-11 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.6 | 7.9 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
1.5 | 11.8 | GO:0007144 | female meiosis I(GO:0007144) |
1.3 | 4.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.3 | 3.9 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.2 | 4.9 | GO:0060032 | notochord regression(GO:0060032) |
1.2 | 6.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.2 | 3.5 | GO:0071314 | cellular response to cocaine(GO:0071314) |
1.1 | 48.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
1.1 | 3.3 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
1.0 | 4.0 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
1.0 | 3.0 | GO:0072194 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) kidney smooth muscle tissue development(GO:0072194) |
1.0 | 3.8 | GO:0061743 | motor learning(GO:0061743) |
0.9 | 6.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.9 | 4.4 | GO:0070103 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.9 | 2.6 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.8 | 4.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.8 | 3.2 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.8 | 7.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.8 | 2.4 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.8 | 3.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.7 | 7.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 2.2 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
0.7 | 1.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.7 | 4.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.7 | 4.1 | GO:0014826 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
0.7 | 10.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.7 | 2.0 | GO:1990523 | bone regeneration(GO:1990523) |
0.7 | 2.0 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.6 | 1.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.6 | 2.3 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.6 | 3.9 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.6 | 5.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.6 | 2.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 1.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 1.6 | GO:0036269 | swimming behavior(GO:0036269) |
0.5 | 4.9 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.5 | 4.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 15.1 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.5 | 2.6 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.5 | 1.5 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.5 | 3.0 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.5 | 5.9 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.5 | 3.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 1.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 6.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.4 | 1.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 3.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.4 | 2.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 1.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.4 | 1.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 1.2 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.4 | 1.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 3.8 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 1.5 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.4 | 1.9 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 1.9 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.4 | 6.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 6.5 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.4 | 1.1 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.4 | 7.6 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.4 | 1.4 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.3 | 1.0 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.3 | 4.0 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.3 | 0.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.3 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.3 | 2.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 4.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.3 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 8.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 1.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 0.9 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.3 | 3.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 2.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 0.9 | GO:0071462 | cellular response to mercury ion(GO:0071288) cellular response to water stimulus(GO:0071462) |
0.3 | 5.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.8 | GO:2000554 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.3 | 1.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.5 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.3 | 0.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 3.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 1.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 2.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 3.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 2.1 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 0.7 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.2 | 1.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.2 | 7.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.7 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 9.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 6.5 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.2 | 0.6 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 0.6 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.2 | 0.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.2 | 2.8 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 2.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 5.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 0.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 5.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 1.9 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 5.3 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 1.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.6 | GO:0046122 | germinal center B cell differentiation(GO:0002314) adenosine catabolic process(GO:0006154) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) purine nucleobase salvage(GO:0043096) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) purine deoxyribonucleoside metabolic process(GO:0046122) regulation of adenosine receptor signaling pathway(GO:0060167) negative regulation of mucus secretion(GO:0070256) |
0.2 | 1.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 3.6 | GO:0080111 | DNA demethylation(GO:0080111) |
0.2 | 1.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.3 | GO:0099541 | retrograde trans-synaptic signaling(GO:0098917) trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
0.2 | 2.6 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.5 | GO:1901675 | response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.2 | 0.3 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.2 | 3.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.4 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.1 | 18.1 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.4 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
0.1 | 0.4 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 1.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.4 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.1 | 0.7 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 1.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 3.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 1.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.9 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.5 | GO:0032202 | telomere assembly(GO:0032202) scaRNA localization to Cajal body(GO:0090666) |
0.1 | 1.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.3 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 1.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 1.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 1.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 3.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 1.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 1.3 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.6 | GO:0060666 | pulmonary myocardium development(GO:0003350) dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 1.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 1.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.6 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.3 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.7 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.4 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.1 | 2.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 1.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 1.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.7 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 1.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 1.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 1.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.4 | GO:0014857 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.2 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.0 | 2.8 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.1 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.0 | 0.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.7 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.5 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 4.0 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.3 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.0 | 1.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.6 | GO:0071548 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 1.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.4 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 1.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 3.6 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.4 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.0 | 0.7 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 1.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 4.2 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) cellular response to actinomycin D(GO:0072717) |
0.0 | 0.7 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.7 | GO:0060004 | reflex(GO:0060004) |
0.0 | 4.3 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 1.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.7 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.0 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.0 | 0.1 | GO:0072513 | semicircular canal morphogenesis(GO:0048752) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.1 | 48.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.9 | 5.7 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
1.4 | 4.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
1.0 | 5.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.0 | 3.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.0 | 17.3 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 0.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.7 | 3.0 | GO:0014802 | terminal cisterna(GO:0014802) |
0.7 | 2.1 | GO:0005940 | septin ring(GO:0005940) |
0.7 | 6.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.7 | 2.7 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.7 | 8.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.6 | 2.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 6.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 1.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.5 | 4.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 1.2 | GO:0005595 | collagen type XII trimer(GO:0005595) anchoring collagen complex(GO:0030934) |
0.4 | 1.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 4.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 19.2 | GO:0031672 | A band(GO:0031672) |
0.3 | 3.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 0.8 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.2 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 0.6 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 0.9 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.2 | 3.5 | GO:0005767 | secondary lysosome(GO:0005767) |
0.2 | 5.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 3.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 6.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 2.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 7.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 1.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.7 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 4.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 3.9 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 1.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 2.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 2.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 7.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 1.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 7.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 4.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 4.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 1.1 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 3.5 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 2.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.4 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 9.1 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 4.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 8.9 | GO:0005819 | spindle(GO:0005819) |
0.1 | 1.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 6.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 1.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 2.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 1.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 8.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 2.5 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 1.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 3.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 7.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 1.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 3.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 1.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 1.3 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 49.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 2.0 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 7.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.2 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.5 | GO:0005930 | axoneme(GO:0005930) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.7 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.7 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.4 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 2.2 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 43.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.0 | 5.9 | GO:0004771 | sterol esterase activity(GO:0004771) retinyl-palmitate esterase activity(GO:0050253) |
1.6 | 12.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.3 | 4.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
1.2 | 6.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.2 | 12.0 | GO:0031014 | troponin T binding(GO:0031014) |
1.1 | 3.3 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.0 | 4.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 6.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.7 | 6.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.7 | 4.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.7 | 2.0 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.6 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.6 | 2.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 1.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.6 | 6.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.5 | 1.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 1.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 2.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.5 | 4.0 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 15.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 1.9 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.5 | 2.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 2.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 8.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 1.7 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 2.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 1.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 1.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 3.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 3.9 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 1.0 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.3 | 1.3 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.3 | 6.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 5.2 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.2 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.3 | 1.2 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 11.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 2.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 1.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 1.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.3 | 2.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 2.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 1.7 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 1.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 4.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 3.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 0.9 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 5.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.2 | 2.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 5.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 1.0 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 5.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 4.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 1.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 6.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 10.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 3.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 1.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 3.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 2.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 1.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.1 | 1.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 5.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 7.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 28.1 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.9 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.1 | 1.9 | GO:0031434 | MAP-kinase scaffold activity(GO:0005078) mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 17.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 4.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 1.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 1.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 4.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.7 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.5 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 5.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 2.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 2.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 3.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 3.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 1.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 2.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.6 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 1.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 1.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.0 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 3.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 1.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 3.4 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 0.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.0 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 8.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 1.8 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 2.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 3.5 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 3.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 3.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 2.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 5.7 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 2.7 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 11.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 12.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 8.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 9.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 14.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 6.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 4.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 10.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 3.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 3.5 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 4.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 3.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 20.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 6.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 3.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 1.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 2.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 2.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.5 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 1.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 3.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 48.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 6.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 11.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 30.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 8.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 15.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 2.6 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 6.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 6.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 4.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 2.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 3.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 5.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 2.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 4.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 3.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 3.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 2.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 5.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 9.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 1.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 1.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 6.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.0 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 1.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 1.2 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 1.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 1.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |